Cargando…
AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
Proliferative retinopathies produces an irreversible type of blindness affecting working age and pediatric population of industrialized countries. Despite the good results of anti-VEGF therapy, intraocular and systemic complications are often associated after its intravitreal use, hence novel therap...
Autores principales: | Iturriaga-Goyon, Emilio, Vivanco-Rojas, Oscar, Magaña-Guerrero, Fátima Sofía, Buentello-Volante, Beatriz, Castro-Salas, Ilse, Aguayo-Flores, José Eduardo, Gracia-Mora, Isabel, Rivera-Huerta, Marisol, Sánchez-Bartés, Francisco, Garfias, Yonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658263/ https://www.ncbi.nlm.nih.gov/pubmed/34884955 http://dx.doi.org/10.3390/ijms222313150 |
Ejemplares similares
-
Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021) -
Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022) -
Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023) -
Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting
por: Miranda, André, et al.
Publicado: (2021) -
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
por: Holmboe, Sif, et al.
Publicado: (2017)